Mauro, M. J., Hehlmann, R., Williams, L. A., Goldberg, S. L., Michallet, M., Gambacorti-Passerini, C., . . . Cortes, J. E. (2025). Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: A prospective, observational study : SIMPLICITY. Leukemia and lymphoma, 66(9), . https://doi.org/10.1080/10428194.2025.2495369
Chicago Style (17th ed.) CitationMauro, Michael J., et al. "Five-year Molecular Response and Overall Survival with First- and Second-generation Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in the Chronic Phase: A Prospective, Observational Study : SIMPLICITY." Leukemia and Lymphoma 66, no. 9 (2025). https://doi.org/10.1080/10428194.2025.2495369.
MLA (9th ed.) CitationMauro, Michael J., et al. "Five-year Molecular Response and Overall Survival with First- and Second-generation Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in the Chronic Phase: A Prospective, Observational Study : SIMPLICITY." Leukemia and Lymphoma, vol. 66, no. 9, 2025, https://doi.org/10.1080/10428194.2025.2495369.